A "glutamatergic hypothesis" of schizophrenia. Rationale for pharmacotherapy with glycine

Clin Neuropharmacol. 1989 Feb;12(1):1-13.

Authors

S I Deutsch¹, J Mastropaolo, B L Schwartz, R B Rosse, J M Morihisa

Affiliation

¹ Psychiatry Service, Veterans Administration Medical Center, Washington, D.C. 20422.

PMID: 2540909

No abstract available

Publication types

Review

MeSH terms

Glutamates / physiology*
Glycine / pharmacology*
Humans
Receptors, N-Methyl-D-Aspartate
Receptors, Neurotransmitter / physiology*
Schizophrenia / physiopathology*
Synaptic Transmission

Substances

Glutamates
Receptors, N-Methyl-D-Aspartate
Receptors, Neurotransmitter
Glycine